Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Paulo Roberto Del Valle"'
Autor:
Bryan E. Strauss, Gissele Rolemberg Oliveira Silva, Igor de Luna Vieira, Otto Luiz Dutra Cerqueira, Paulo Roberto Del Valle, Ruan Felipe Vieira Medrano, Samir Andrade Mendonça
Publikováno v:
Clinics, Vol 73, Iss suppl 1 (2018)
While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that t
Externí odkaz:
https://doaj.org/article/9e494274f77b4c3394d29735776f8fce
Autor:
Paulo Roberto Del Valle, Cintia Milani, Maria Mitzi Brentani, Maria Lucia Hirata Katayama, Eduardo Carneiro de Lyra, Dirce Maria Carraro, Helena Brentani, Renato Puga, Leandro A. Lima, Patricia Bortman Rozenchan, Bárbara dos Santos Nunes, João Carlos Guedes Sampaio Góes, Maria Aparecida Azevedo Koike Folgueira
Publikováno v:
Genetics and Molecular Biology, Vol 37, Iss 3, Pp 480-489 (2014)
Cancer-associated fibroblasts (CAF) influence tumor development at primary as well as in metastatic sites, but there have been no direct comparisons of the transcriptional profiles of stromal cells from different tumor sites. In this study, we used c
Externí odkaz:
https://doaj.org/article/a8858a76469b47ef9a39ad9657c69d15
Autor:
Paulo Roberto Del Valle
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
Introdução: Em câncer de mama, existem evidências de que o microambiente pode influenciar o desenvolvimento do tumor no sítio primário, bem como em metástases regionais e a distância. Neste contexto, fibroblastos são importantes células est
Autor:
Samir Andrade Mendonça, Fernanda Antunes, Otto L.D. Cerqueira, Paulo Roberto Del Valle, Aline Hunger, Percíllia V.S. de Oliveira, Barbara Brito, Eugenia Costanzi-Strauss, Bryan E. Strauss
Publikováno v:
DNA and Cell Biology.
Autor:
Rodrigo Esaki Tamura, Samir Andrade Mendonça, Fernanda Antunes, Bryan E. Strauss, Daniela B Zanatta, Aline Hunger, Paulo Roberto Del Valle
Publikováno v:
Cancer Biol Ther
While treatments for colorectal cancer continue to improve, some 50% of patients succumb within 5 years, pointing to the need for additional therapeutic options. We have developed a modified non-replicating adenoviral vector for gene transfer, called
Autor:
Paulo Roberto Del Valle, Jonathan B. Bell, Scott M. Welford, Kaylie Kullison, Alessandro Valderrama, Gregory A. Azzam, Jessica J. Meshman, Macarena I. De La Fuente, Eric A. Mellon
Publikováno v:
Cancer Research. 83:2162-2162
Intro. Glioblastoma is the most common and aggressive adult brain cancer, with a 5-year survival of less than 15%. Treatment decisions are guided by imaging, which at early timepoints cannot distinguish tumor pseudoprogression from non-response. Our
Autor:
Eugenia Costanzi-Strauss, Daniela B Zanatta, Ruan F.V. Medrano, Bryan E. Strauss, Guido Kroemer, João Paulo Portela Catani, Sandy Adjemian, Aline Hunger, Paulo Roberto Del Valle
Publikováno v:
Translational Oncology
Translational Oncology, Elsevier, 2016, 9 (6), pp.565-574. ⟨10.1016/j.tranon.2016.09.011⟩
Translational Oncology, Elsevier, 2016, 9 (6), pp.565-574. 〈10.1016/j.tranon.2016.09.011〉
Translational Oncology, Vol 9, Iss 6, Pp 565-574 (2016)
Translational Oncology, 2016, 9 (6), pp.565-574. ⟨10.1016/j.tranon.2016.09.011⟩
Translational Oncology, Elsevier, 2016, 9 (6), pp.565-574. ⟨10.1016/j.tranon.2016.09.011⟩
Translational Oncology, Elsevier, 2016, 9 (6), pp.565-574. 〈10.1016/j.tranon.2016.09.011〉
Translational Oncology, Vol 9, Iss 6, Pp 565-574 (2016)
Translational Oncology, 2016, 9 (6), pp.565-574. ⟨10.1016/j.tranon.2016.09.011⟩
International audience; Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but may benefit from the induction of both cell death and immune activation as pri
Autor:
Otto Luiz Dutra Cerqueira, Igor de Luna Vieira, Samir Andrade Mendonça, Paulo Roberto Del Valle, Gissele Rolemberg Oliveira Silva, Ruan F.V. Medrano, Bryan E. Strauss
Publikováno v:
Clinics; v. 73 n. Suppl. 1 (2018); e479s
Clinics; Vol. 73 Núm. Suppl. 1 (2018); e479s
Clinics; Vol. 73 No. Suppl. 1 (2018); e479s
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 73, Iss suppl 1 (2018)
Clinics, Volume: 73 Supplement 1, Article number: e479s, Published: 06 SEP 2018
Clinics; Vol. 73 Núm. Suppl. 1 (2018); e479s
Clinics; Vol. 73 No. Suppl. 1 (2018); e479s
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 73, Iss suppl 1 (2018)
Clinics, Volume: 73 Supplement 1, Article number: e479s, Published: 06 SEP 2018
While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501dcd5415c200fca083aafa0dc241c1
https://www.revistas.usp.br/clinics/article/view/154791
https://www.revistas.usp.br/clinics/article/view/154791
Autor:
Daniela B Zanatta, Thiago A. Salles, Eugenia Costanzi-Strauss, Paulo Roberto Del Valle, Aline Hunger, Tatiane Katsue Furuya, Silvina Odete Bustos, Renata de Freitas Saito, Bryan E. Strauss, Daniel G. Ferrari, Ruan Fv Medrano, Christian A. Merkel
Publikováno v:
Cell Death Discovery
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Late stage melanoma continues to be quite difficult to treat and new therapeutic approaches are needed. Since these tumors often retain wild-type p53 and have a strong immunogenic potential, we developed a gene transfer approach which targets these c
Autor:
Paulo Roberto Del Valle, René Aloisio da Costa Vieira, Maria Mitzi Brentani, Maria Aparecida Azevedo Koike Folgueira, I. Snitcovsky, Maria Lucia Hirata Katayama
Publikováno v:
ResearcherID
Summary Objective To improve the accuracy predictive models of response to neoadjuvant chemotherapy in breast cancer, cDNA microarray technology was used to study tumor transcriptional profile. Gene signatures associated with predicting the response